# Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer

> **NCT03679338** · PHASE2 · COMPLETED · sponsor: **Institut Paoli-Calmettes** · enrollment: 20 (actual)

## Conditions studied

- Nonresectable Bile Duct Cancer

## Interventions

- **DEVICE:** Ablation Therapy

## Key facts

- **NCT ID:** NCT03679338
- **Lead sponsor:** Institut Paoli-Calmettes
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-03-22
- **Primary completion:** 2021-03-18
- **Final completion:** 2022-03-11
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2023-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679338

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679338, "Prospective Evaluation of the Ablation Therapy With Bipolar Radio Frequency for Nonresectable Bile Duct Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03679338. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*